ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years

Sara Sofia De Lucia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3644-8063; OpenAlex author ID A5024364305. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Co-author DOI 10.3390/cancers17223618 ↗
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. First author DOI 10.3390/cancers15133423 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marcello Candelli · 2 shared papers, 2023–2025 · strength 0.43
- Paper Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial … DOI 10.3390/cancers17223618 ↗
- Paper State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. DOI 10.3390/cancers15133423 ↗
Enrico Celestino Nista · 2 shared papers, 2023–2025 · strength 0.43
- Paper Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial … DOI 10.3390/cancers17223618 ↗
- Paper State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. DOI 10.3390/cancers15133423 ↗
Giulia Pignataro · 1 shared paper, 2025 · strength 0.26
- Paper Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial … DOI 10.3390/cancers17223618 ↗
Tommaso Schepis · 1 shared paper, 2023 · strength 0.17
- Paper State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. DOI 10.3390/cancers15133423 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.